{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:23:55Z","timestamp":1792196635634,"version":"4.4.0"},"reference-count":23,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Brigham Young University https:\/\/ror.org\/047rhhm47"},{"id":[{"id":"https:\/\/ror.org\/047rhhm47","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>Background\/Objectives: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), particularly semaglutide, have demonstrated efficacy for weight loss in obesity; however, up to 40% of weight lost may derive from lean body mass. The ketogenic diet independently improves insulin sensitivity and promotes fat oxidation while preserving lean tissue. This study aimed to describe changes in body composition, insulin sensitivity, and cardiometabolic markers in patients who followed a personalized ketogenic dietary protocol while receiving low-dose semaglutide over a 6-month insulin resistance reversal program. Methods: Seven analyzed adults (six female, one male) with overweight or obesity (baseline BMI 25.6\u201347.2 kg\/m2) participated in a clinician-supervised 6-month program combining a whole-food ketogenic diet with semaglutide (\u22641.0 mg\/week). Body composition and fasting metabolic markers were assessed at 1, 3, and 6 months. Results: Mean total weight loss was 21.9 kg, of which a mean of 92% was attributable to BIA-estimated fat mass. Skeletal muscle mass was largely preserved as measured by BIA (mean loss 1.2 kg), and one patient gained lean tissue. Fasting insulin declined by a mean of 15.6 \u00b5IU\/mL. Visceral fat decreased by a mean of 37.0%. Six of seven patients showed reductions in high-sensitivity C-reactive protein. Triglycerides decreased in six of seven patients, and HDL cholesterol increased in all seven. LDL cholesterol responses were heterogeneous. Conclusions: In this small, uncontrolled case series, combining a ketogenic diet with low-dose semaglutide was associated with substantial fat loss, apparent preservation of lean mass as measured by BIA, and improvements in insulin sensitivity and cardiometabolic markers. Because the semaglutide dose and dietary protocol were individualized to each patient\u2019s response, the program illustrates a personalized approach to insulin resistance. These preliminary findings are hypothesis-generating and warrant confirmation in controlled prospective studies.<\/jats:p>","DOI":"10.3390\/jpm16060313","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T06:53:10Z","timestamp":1781247190000},"page":"313","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Personalized Combination of a Ketogenic Diet and Low-Dose Semaglutide for Cardiometabolic Health: A Retrospective Case Series"],"prefix":"10.3390","volume":"16","author":[{"given":"Genevieve","family":"Parker","sequence":"first","affiliation":[{"name":"Department of Cell Biology and Physiology, Brigham Young University, Provo, UT 84604, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline D.","family":"Morris","sequence":"additional","affiliation":[{"name":"Department of Cell Biology and Physiology, Brigham Young University, Provo, UT 84604, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeter R.","family":"Heggie","sequence":"additional","affiliation":[{"name":"Department of Cell Biology and Physiology, Brigham Young University, Provo, UT 84604, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1307-1943","authenticated-orcid":false,"given":"Ella F.","family":"Cooper-Leavitt","sequence":"additional","affiliation":[{"name":"Department of Cell Biology and Physiology, Brigham Young University, Provo, UT 84604, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron J.","family":"Clark","sequence":"additional","affiliation":[{"name":"Department of Cell Biology and Physiology, Brigham Young University, Provo, UT 84604, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asher P.","family":"Reynolds","sequence":"additional","affiliation":[{"name":"Department of Cell Biology and Physiology, Brigham Young University, Provo, UT 84604, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly A.","family":"Smith","sequence":"additional","affiliation":[{"name":"Summit Family Health-Metabolic Clinic, Meridian, ID 83642, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlie P.","family":"Wendel","sequence":"additional","affiliation":[{"name":"Summit Family Health-Metabolic Clinic, Meridian, ID 83642, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Jensen","sequence":"additional","affiliation":[{"name":"Summit Family Health-Metabolic Clinic, Meridian, ID 83642, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1457-591X","authenticated-orcid":false,"given":"Tyson J.","family":"Morris","sequence":"additional","affiliation":[{"name":"School of Medicine, Creighton University, Phoenix, AZ 85012, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Reynolds","sequence":"additional","affiliation":[{"name":"Department of Cell Biology and Physiology, Brigham Young University, Provo, UT 84604, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3680-6906","authenticated-orcid":false,"given":"Benjamin T.","family":"Bikman","sequence":"additional","affiliation":[{"name":"Department of Cell Biology and Physiology, Brigham Young University, Provo, UT 84604, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1463-1326.2005.00521.x","article-title":"Insulin resistance--a common link between type 2 diabetes and cardiovascular disease","volume":"8","author":"Lebovitz","year":"2006","journal-title":"Diabetes Obes. Metab."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Vaidya, R.A., Desai, S., Moitra, P., Salis, S., Agashe, S., Battalwar, R., Mehta, A., Madan, J., Kalita, S., and Udipi, S.A. (2023). Hyperinsulinemia: An early biomarker of metabolic dysfunction. Front. Clin. Diabetes Healthc., 4.","DOI":"10.3389\/fcdhc.2023.1159664"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","article-title":"Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1","volume":"27","author":"Drucker","year":"2018","journal-title":"Cell Metab."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-Weekly Semaglutide in Adults with Overweight or Obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.2337\/dc24-1082","article-title":"Real-World Use of Semaglutide for Weight Management: Patient Characteristics and Dose Titration-A Danish Cohort Study","volume":"47","author":"Ladebo","year":"2024","journal-title":"Diabetes Care"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: Revised European consensus on definition and diagnosis","volume":"48","author":"Bahat","year":"2019","journal-title":"Age Ageing"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1053\/meta.2002.32037","article-title":"Body composition and hormonal responses to a carbohydrate-restricted diet","volume":"51","author":"Volek","year":"2002","journal-title":"Metabolism"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nut.2014.06.011","article-title":"Dietary carbohydrate restriction as the first approach in diabetes management: Critical review and evidence base","volume":"31","author":"Feinman","year":"2015","journal-title":"Nutrition"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12933-018-0698-8","article-title":"Cardiovascular disease risk factor responses to a type 2 diabetes care model including nutritional ketosis induced by sustained carbohydrate restriction at 1 year: An open label, non-randomized, controlled study","volume":"17","author":"Bhanpuri","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.clnu.2024.06.034","article-title":"Metabolic effects of very-low calorie diet, Semaglutide, or combination of the two, in individuals with type 2 diabetes mellitus","volume":"43","author":"Anyiam","year":"2024","journal-title":"Clin. Nutr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/ajcn\/nqy170","article-title":"Effects of 3-hydroxybutyrate and free fatty acids on muscle protein kinetics and signaling during LPS-induced inflammation in humans: Anticatabolic impact of ketone bodies","volume":"108","author":"Thomsen","year":"2018","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.nutr.26.061505.111258","article-title":"Fuel metabolism in starvation","volume":"26","author":"Cahill","year":"2006","journal-title":"Annu. Rev. Nutr."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Walton, C.M., Jacobsen, S.M., Dallon, B.W., Saito, E.R., Bennett, S.L.H., Davidson, L.E., Thomson, D.M., Hyldahl, R.D., and Bikman, B.T. (2020). Ketones Elicit Distinct Alterations in Adipose Mitochondrial Bioenergetics. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21176255"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Roeth, E.J., Parker, G., Cooper-Leavitt, E.F., Beus, C.G., Braithwaite, C.R., Morris, M.D., Reynolds, A.P., Evans, E.P., Radford, J.H., and Davis, F.D. (2025). Effect of Exogenous Ketones as an Adjunct to Low-Calorie Diet on Metabolic Markers. Nutrients, 17.","DOI":"10.3390\/nu17223582"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1172\/JCI43378","article-title":"Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice","volume":"121","author":"Holland","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/dom.12932","article-title":"Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity","volume":"19","author":"Blundell","year":"2017","journal-title":"Diabetes Obes. Metab."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/s11096-022-01428-1","article-title":"Efficacy of subcutaneous semaglutide compared to placebo for weight loss in obese, non-diabetic adults: A systematic review & meta-analysis","volume":"44","author":"Arastu","year":"2022","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1161\/CIRCULATIONAHA.111.067264","article-title":"Body fat distribution and risk of cardiovascular disease: An update","volume":"126","author":"Despres","year":"2012","journal-title":"Circulation"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1017\/S0007114513000548","article-title":"Very-low-carbohydrate ketogenic diet v. low-fat diet for long-term weight loss: A meta-analysis of randomised controlled trials","volume":"110","author":"Bueno","year":"2013","journal-title":"Br. J. Nutr."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/nutrit\/nuy049","article-title":"Effects of carbohydrate-restricted diets on low-density lipoprotein cholesterol levels in overweight and obese adults: A systematic review and meta-analysis","volume":"77","author":"Davies","year":"2019","journal-title":"Nutr. Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/ajcn\/53.6.1404","article-title":"The transient hypercholesterolemia of major weight loss","volume":"53","author":"Phinney","year":"1991","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"802","DOI":"10.7326\/0003-4819-139-10-200311180-00007","article-title":"Use of metabolic markers to identify overweight individuals who are insulin resistant","volume":"139","author":"Mclaughlin","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e085304","DOI":"10.1136\/bmj-2025-085304","article-title":"Weight regain after cessation of medication for weight management: Systematic review and meta-analysis","volume":"392","author":"West","year":"2026","journal-title":"BMJ"}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/16\/6\/313\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T07:37:15Z","timestamp":1781249835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/16\/6\/313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":23,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["jpm16060313"],"URL":"https:\/\/doi.org\/10.3390\/jpm16060313","relation":{},"ISSN":["2075-4426"],"issn-type":[{"value":"2075-4426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]}}}